AWM
CTSO icon

AE Wealth Management’s Cytosorbents Corp CTSO Stock Holding History

AE Wealth Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,783
Closed -$49.5K – 1973
2023
Q2 		$49.5K Buy
+13,783
New +$43.6K ﹤0.01% 1836

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

AE Wealth Management's CTSO Position: Q3 2023 in Review

AE Wealth Management sold out of Cytosorbents Corp (CTSO) in Q3 2023, closing a stake of 13,783 shares — an estimated $49.5K sold.

AE Wealth Management first reported a position in CTSO in Q2 2023 and held it in 1 quarter. The position peaked at $49.5K in Q2 2023. 53 funds tracked by Wall St. Rank hold CTSO as of Q3 2023.

  • AE Wealth Management reported no remaining Cytosorbents Corp position as of Q3 2023 after selling out during the quarter.
  • AE Wealth Management sold 13,783 Cytosorbents Corp shares in Q3 2023, an estimated $49.5K.
  • AE Wealth Management first reported a position in Cytosorbents Corp in Q2 2023 and held it in 1 quarter.
  • AE Wealth Management's Cytosorbents Corp position peaked at $49.5K in Q2 2023.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2023.

Based on AE Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.